Pharmaceutically acc... 申请号：US15309981 专利类型：发明授权 公开（公告）日：2014-05-09
状态：寻求转化 转让价格：面议
The present invention provides pharmaceutically acceptable salts of enantiomerically pure (R)-pirlindole and (S)-pirlindole compounds having an increased bioavailability profile for use in medicine.
Pharmaceutically acc... 申请号：KR1020187035905 专利类型：发明申请 公开（公告）日：2017-06-06
状态：寻求转化 转让价格：面议
Provided is a pharmaceutically acceptable salt as a renal outer medullary potassium channel (ROMK) inhibitor, specifically an L-tartrate and a crystal form I and crystal form II thereof. The pharmace...
Pharmaceutical salt ... 申请号：AU2016251707 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The mesylate and sulphate salts of (3S)-Tetrahydrofuran-3-yl (4S)-4-isopropyl-, 4, 6, 7-tetrahydro-5H-imidazo[4, 5-c]pyridine-5-carboxylate mesylate, and hydrates thereof, and their use in medicine.
Pharmaceutical salt ... 申请号：US15567536 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The mesylate and sulphate salts of (3S)-Tetrahydrofuran-3-yl (4S)-4-isopropyl-, 4, 6, 7-tetrahydro-5H-imidazo[4, 5-c]pyridine-5-carboxylate mesylate, and hydrates thereof, and their use in medicine.
Pharmaceutical salt ... 申请号：AU2016251707 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The mesylate and sulphate salts of (3S)-Tetrahydrofuran-3-yl (4S)-4-isopropyl-, 4, 6, 7-tetrahydro-5H-imidazo[4, 5-c]pyridine-5-carboxylate mesylate, and hydrates thereof, and their use in medicine.
Pharmaceutical sales... 申请号：JP2018204081 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
[Problem] non-prescription drug in the sales, purchase cost advantages while providing a medicine, a payment system can avoid an increase in the load of the auxiliary excess unions. [Solution] a ph...
Pharmaceutical raw m... 申请号：IES20180078 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
Pharmaceutical raw materials hexafluoroacetone synthesis method, comprises the following steps : 3 mol 2, 3-dihydroxy-hexafluoroisopentane and 4-6 mol N-methylpropionamide were added to the reaction...
Pharmaceutical raw m... 申请号：IES20180078 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
Pharmaceutical raw materials hexafluoroacetone synthesis method, comprises the following steps : 3 mol 2, 3-dihydroxy-hexafluoroisopentane and 4-6 mol N-methylpropionamide were added to the reaction...
